Literature DB >> 21051843

Management of aerobic vaginitis.

Gianna Tempera1, Pio Maria Furneri.   

Abstract

Aerobic vaginitis is a new nonclassifiable pathology that is neither specific vaginitis nor bacterial vaginosis. The diversity of this microbiological peculiarity could also explain several therapeutic failures when patients were treated for infections identified as bacterial vaginosis. The diagnosis 'aerobic vaginitis' is essentially based on microscopic examinations using a phase-contrast microscope (at ×400 magnification). The therapeutic choice for 'aerobic vaginitis' should take into consideration an antibiotic characterized by an intrinsic activity against the majority of bacteria of fecal origin, bactericidal effect and poor/absent interference with the vaginal microbiota. Regarding the therapy for aerobic vaginitis when antimicrobial agents are prescribed, not only the antimicrobial spectrum but also the presumed ecological disturbance on the anaerobic and aerobic vaginal and rectal microbiota should be taken into a consideration. Because of their very low impact on the vaginal microbiota, kanamycin or quinolones are to be considered a good choice for therapy.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051843     DOI: 10.1159/000314013

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  13 in total

1.  Selecting anti-microbial treatment of aerobic vaginitis.

Authors:  Gilbert G G Donders; Katerina Ruban; Gert Bellen
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

2.  Increased vaginal pH in Ugandan women: what does it indicate?

Authors:  G G G Donders; A Gonzaga; C Marconi; F Donders; T Michiels; N Eggermont; G Bellen; J Lule; J Byamughisa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-14       Impact factor: 3.267

3.  Efficacy of oral moxifloxacin for aerobic vaginitis.

Authors:  C Wang; C Han; N Geng; A Fan; Y Wang; Y Yue; H Zhang; F Xue
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-02       Impact factor: 3.267

Review 4.  A new era of the vaginal microbiome: advances using next-generation sequencing.

Authors:  Jennifer M Fettweis; Myrna G Serrano; Philippe H Girerd; Kimberly K Jefferson; Gregory A Buck
Journal:  Chem Biodivers       Date:  2012-05       Impact factor: 2.408

5.  Vaginal Microbiota Evaluation and Lactobacilli Quantification by qPCR in Pregnant and Non-pregnant Women: A Pilot Study.

Authors:  David Pacha-Herrera; Gabriela Vasco; Cecilia Cruz-Betancourt; Juan Miguel Galarza; Verónica Barragán; António Machado
Journal:  Front Cell Infect Microbiol       Date:  2020-06-19       Impact factor: 5.293

6.  The role of the miR1976/CD105/integrin αvβ6 axis in vaginitis induced by Escherichia coli infection in mice.

Authors:  Lisha Jiang; Lingling Zhang; Can Rui; Xia Liu; Zhiyuan Mao; Lina Yan; Ting Luan; Xinyan Wang; Ying Wu; Ping Li; Xin Zeng
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

7.  Silver sucrose octasulfate (IASOS™) as a valid active ingredient into a novel vaginal gel against human vaginal pathogens: in vitro antimicrobial activity assessment.

Authors:  Cinzia Marianelli; Paola Petrucci; Maria Cristina Comelli; Gabriella Calderini
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

8.  Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Piotr B Heczko; Anna Tomusiak; Paweł Adamski; Artur J Jakimiuk; Grzegorz Stefański; Aleksandra Mikołajczyk-Cichońska; Magdalena Suda-Szczurek; Magdalena Strus
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

Review 9.  Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis.

Authors:  Evelyn Kaambo; Charlene Africa; Ramadhani Chambuso; Jo-Ann Shelley Passmore
Journal:  Front Public Health       Date:  2018-03-26

10.  Commentary: Lactobacilli Dominance and Vaginal pH: Why Is the Human Vaginal Microbiome Unique?

Authors:  Virginia Fuochi; Giovanni Li Volti; Pio Maria Furneri
Journal:  Front Microbiol       Date:  2017-09-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.